Belite Bio BLTE
NASDAQ BLTE
$162.98 -6.84 (-4.03%)
At close: Oct 1, 2026 · 4:00 PM EDT

Belite Bio (BLTE) Cash from Financing Activities (2021 - 2025)

Updated

Belite Bio (BLTE) reported Cash from Financing Activities of $510.12 million for Q4 2025, compared with $39.78 million a year earlier.

Analysis

Belite Bio (BLTE) Cash from Financing Activities (2021 - 2025) Analysis & Trends

For FY2025, Belite Bio posted Cash from Financing Activities of $663.23 million, up 693.4% from FY2024.

  • Cash from Financing Activities has increased for three consecutive years, with a five-year compound annual growth rate of 88.2% (FY2020 to FY2025).
  • By year, Cash from Financing Activities came in at $83.6 million in FY2024 (+10.1%), $75.96 million in FY2023 (+105.5%), $36.96 million in FY2022 and -$583,000 in FY2021.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash from Financing (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn -8.78 Bn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn -5.05 Bn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn 1.76 Bn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn -2.02 Bn
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn -47.00 Mn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn -1.48 Bn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn 2.34 Bn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn -3.66 Bn
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn -426.70 Mn
10 Belite Bio 6.68 Bn 6.68 Bn - -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2025 510.12 Mn
Dec 31, 2024 39.78 Mn
Dec 31, 2021 -583,000.00
API Access

Belite Bio Cash from Financing Activities API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=cash-from-financing-activities&ticker=BLTE&period=max&api_key=YOUR_API_KEY